121 related articles for article (PubMed ID: 18082901)
1. Quantitative evaluation of viral fitness due to a single nucleotide polymorphism in the Marek's disease virus UL41 gene via an in vitro competition assay.
Mao W; Niikura M; Silva RF; Cheng HH
J Virol Methods; 2008 Mar; 148(1-2):125-31. PubMed ID: 18082901
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the Marek's disease virus UL41 gene (vhs) has no measurable effect on latency or pathogenesis.
Gimeno I; Silva RF
Virus Genes; 2008 Jun; 36(3):499-507. PubMed ID: 18311518
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
4. Direct evidence of host genome acquisition by the alphaherpesvirus Marek's disease virus.
Niikura M; Dodgson J; Cheng H
Arch Virol; 2006 Mar; 151(3):537-49. PubMed ID: 16155725
[TBL] [Abstract][Full Text] [Related]
5. Characterizing the molecular basis of attenuation of Marek's disease virus via in vitro serial passage identifies de novo mutations in the helicase-primase subunit gene UL5 and other candidates associated with reduced virulence.
Hildebrandt E; Dunn JR; Perumbakkam S; Niikura M; Cheng HH
J Virol; 2014 Jun; 88(11):6232-42. PubMed ID: 24648463
[TBL] [Abstract][Full Text] [Related]
6. Development of a sustainable chick cell line infected with Marek's disease virus.
Abujoub A; Coussens PM
Virology; 1995 Dec; 214(2):541-9. PubMed ID: 8553556
[TBL] [Abstract][Full Text] [Related]
7. Stability of Marek's disease virus 132-bp repeats during serial in vitro passages.
Niikura M; Dodgson JB; Cheng HH
Arch Virol; 2006 Jul; 151(7):1431-8. PubMed ID: 16489507
[TBL] [Abstract][Full Text] [Related]
8. Viral pathogenesis in chicken embryos and tumor induction in chickens after in ovo exposure to serotype 1 Marek's disease virus.
St Hill CA; Sharma JM
Avian Dis; 2000; 44(4):842-52. PubMed ID: 11195638
[TBL] [Abstract][Full Text] [Related]
9. Marek's disease virus (Kekava strain) replication in chickens, chick embryos and cell cultures.
Yakovleva LS; Mazurenko NP; Gunenkova NK; Vinogradov VN; Pavlovskaya AI; Chernyakhovskaya IY
Acta Virol; 1975 Jul; 19(4):293-8. PubMed ID: 241226
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional analysis of Marek's disease virus glycoprotein D, I, and E genes: gD expression is undetectable in cell culture.
Tan X; Brunovskis P; Velicer LF
J Virol; 2001 Mar; 75(5):2067-75. PubMed ID: 11160711
[TBL] [Abstract][Full Text] [Related]
11. The virion host shutoff protein of herpes simplex virus inhibits reporter gene expression in the absence of other viral gene products.
Pak AS; Everly DN; Knight K; Read GS
Virology; 1995 Aug; 211(2):491-506. PubMed ID: 7645253
[TBL] [Abstract][Full Text] [Related]
12. The protein encoded by the US3 orthologue of Marek's disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown.
Schumacher D; Tischer BK; Trapp S; Osterrieder N
J Virol; 2005 Apr; 79(7):3987-97. PubMed ID: 15767401
[TBL] [Abstract][Full Text] [Related]
13. Effect of native chicken interferon on MDV replication.
Levy AM; Heller ED; Leitner G; Davidson I
Acta Virol; 1999; 43(2-3):121-7. PubMed ID: 10696431
[TBL] [Abstract][Full Text] [Related]
14. Identification and transcriptional analysis of the homologues of the herpes simplex virus type 1 UL41 to UL51 genes in the genome of nononcogenic Marek's disease virus serotype 2.
Izumiya Y; Jang HK; Kashiwase H; Cai JS; Nishimura Y; Tsushima Y; Kato K; Miyazawa T; Kai C; Mikami T
J Gen Virol; 1998 Aug; 79 ( Pt 8)():1997-2001. PubMed ID: 9714249
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
[TBL] [Abstract][Full Text] [Related]
16. A mass spectrometry-based proteomic approach to study Marek's Disease Virus gene expression.
Liu HC; Soderblom EJ; Goshe MB
J Virol Methods; 2006 Jul; 135(1):66-75. PubMed ID: 16563527
[TBL] [Abstract][Full Text] [Related]
17. Purification of DNA from the cell-associated herpesvirus Marek's disease virus for 454 pyrosequencing using micrococcal nuclease digestion and polyethylene glycol precipitation.
Volkening JD; Spatz SJ
J Virol Methods; 2009 Apr; 157(1):55-61. PubMed ID: 19103224
[TBL] [Abstract][Full Text] [Related]
18. The herpes simplex virus type 1 vhs-UL41 gene secures viral replication by temporarily evading apoptotic cellular response to infection: Vhs-UL41 activity might require interactions with elements of cellular mRNA degradation machinery.
Barzilai A; Zivony-Elbom I; Sarid R; Noah E; Frenkel N
J Virol; 2006 Jan; 80(1):505-13. PubMed ID: 16352574
[TBL] [Abstract][Full Text] [Related]
19. Construction of an infectious Marek's disease virus bacterial artificial chromosome and characterization of protection induced in chickens.
Cui HY; Wang YF; Shi XM; An TQ; Tong GZ; Lan DS; He L; Liu CJ; Wang M
J Virol Methods; 2009 Mar; 156(1-2):66-72. PubMed ID: 19026690
[TBL] [Abstract][Full Text] [Related]
20. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
Baigent SJ; Smith LP; Nair VK; Currie RJ
Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
